News Daily News FOURIER Surveys Reassure About Cognitive Safety of Evolocumab Todd Neale May 06, 2020
News Daily News COVID-19, ACE Inhibitors, and ARBs: Multiple Studies Show No Increased Risk Michael O'Riordan May 05, 2020
News Daily News Remdesivir Study for COVID-19 Yields Positive Top-line Results Michael O'Riordan April 29, 2020
News Daily News Pulmonary Embolism in COVID-19 Patients: New Numbers, Little Consensus Michael O'Riordan April 29, 2020
News Conference News ACC 2020 Pooled Inclisiran Data: Safe LDL-Lowering, Plus Hints of Fewer CVD Events Michael O'Riordan April 02, 2020
News Conference News ACC 2020 ISCHEMIA in Print: New MI Data and More Calls for Longer Follow-up Shelley Wood March 30, 2020
News Conference News ACC 2020 Diabetes May Boost Benefits of COMPASS Dual Antithrombotic Approach Todd Neale March 28, 2020
News Daily News Missed Opportunities: Many HF Patients Not Tested for CAD L.A. McKeown March 20, 2020
News Daily News Type 2 MI Linked to More CV Deaths, Even in Younger Patients Shelley Wood March 04, 2020
News Conference News ISC 2020 Telehealth Program Helps Minority Stroke Survivors Control BP Todd Neale February 26, 2020
News Daily News Nearly Half of Diabetic Patients Struggle to Pay Medical Bills Michael O'Riordan February 12, 2020
News Daily News Long-term Evolocumab Safe, Effective for Familial Hypercholesterolemia Treatment Yael L. Maxwell February 12, 2020
News Daily News Stent-Related Adverse Events Continue Out to 5 Years: Meta-analysis Michael O'Riordan February 10, 2020
News Daily News Free Pass? Lifestyle Slips for Patients Starting Certain Preventive Meds Michael O'Riordan February 06, 2020
News Daily News Ticagrelor Hits Mark in Large Stroke Study: THALES Top-line Results Michael O'Riordan January 27, 2020
News Daily News Pot Talk: Review Urges Cardiologists to Discuss Marijuana Use L.A. McKeown January 21, 2020
News Daily News Lp(a) Reduction Contributes to Alirocumab’s Treatment Benefit: ODYSSEY Outcomes Michael O'Riordan January 14, 2020
News Features ‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry Michael O'Riordan January 10, 2020
News Daily News Most Secondary Prevention Patients Are Eligible for Multiple Drugs Michael O'Riordan January 03, 2020
News Conference News AHA 2019 Full GALILEO Results Confirm Harm With Rivaroxaban After TAVR Todd Neale November 17, 2019